JP2025509846A5 - - Google Patents
Info
- Publication number
- JP2025509846A5 JP2025509846A5 JP2024555367A JP2024555367A JP2025509846A5 JP 2025509846 A5 JP2025509846 A5 JP 2025509846A5 JP 2024555367 A JP2024555367 A JP 2024555367A JP 2024555367 A JP2024555367 A JP 2024555367A JP 2025509846 A5 JP2025509846 A5 JP 2025509846A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- alkyl
- compound
- oxygen
- unsubstituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263319582P | 2022-03-14 | 2022-03-14 | |
| US63/319,582 | 2022-03-14 | ||
| PCT/US2023/015024 WO2023177593A1 (en) | 2022-03-14 | 2023-03-10 | Phenyl triazole mll1-wdr5 protein-protein interaction inhibitor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025509846A JP2025509846A (ja) | 2025-04-11 |
| JP2025509846A5 true JP2025509846A5 (cg-RX-API-DMAC7.html) | 2026-03-17 |
Family
ID=87932382
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024555367A Pending JP2025509846A (ja) | 2022-03-14 | 2023-03-10 | フェニルトリアゾールmll1-wdr5タンパク質-タンパク質間相互作用阻害剤 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230286925A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4493182A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025509846A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20250023339A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3245868A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024011348A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023177593A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109734674B (zh) * | 2019-02-26 | 2022-08-26 | 中国药科大学 | 苯胺类wdr5蛋白-蛋白相互作用抑制剂及其制法和用途 |
| WO2025155755A1 (en) * | 2024-01-16 | 2025-07-24 | Rutgers, The State University Of New Jersey | Sterically hindered 1h-1,2,3-triazol-5-ylidene abnormal n-heterocyclic carbene (anhc) ligands, catalyst complexes thereof, and methods using same |
| TW202619730A (zh) | 2024-09-13 | 2026-05-16 | 日商亞力維克希斯股份有限公司 | Wdr5抑制劑、化合物、醫藥組合物、及其使用方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7511042B2 (en) * | 2003-12-03 | 2009-03-31 | Boehringer Ingelheim Pharmaceuticals, Inc. | Triazole compounds |
| WO2015187827A1 (en) * | 2014-06-03 | 2015-12-10 | The Trustees Of The University Of Pennsylvania | Novel effective antiviral compounds and methods using same |
| US11319299B2 (en) * | 2016-03-01 | 2022-05-03 | Propellon Therapeutics Inc. | Substituted carboxamides as inhibitors of WDR5 protein-protein binding |
| JP2020532561A (ja) * | 2017-09-06 | 2020-11-12 | プロペロン セラピューティクス インコーポレイテッド | Wdr5タンパク質−タンパク質結合の阻害剤 |
| CN108715585A (zh) * | 2018-04-23 | 2018-10-30 | 中国药科大学 | 苯基联三氮唑类mll1-wdr5蛋白-蛋白相互作用抑制剂 |
| JP2021527666A (ja) * | 2018-06-21 | 2021-10-14 | アイカーン スクール オブ メディスン アット マウント シナイ | Wd40反復ドメインタンパク質5(wdr5)分解/破壊化合物および使用の方法 |
-
2023
- 2023-03-10 CA CA3245868A patent/CA3245868A1/en active Pending
- 2023-03-10 JP JP2024555367A patent/JP2025509846A/ja active Pending
- 2023-03-10 US US18/120,318 patent/US20230286925A1/en active Pending
- 2023-03-10 WO PCT/US2023/015024 patent/WO2023177593A1/en not_active Ceased
- 2023-03-10 EP EP23771269.0A patent/EP4493182A4/en active Pending
- 2023-03-10 KR KR1020247034050A patent/KR20250023339A/ko active Pending
-
2024
- 2024-09-13 MX MX2024011348A patent/MX2024011348A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10301278B2 (en) | 1-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions therefor for inhibiting the activity of SHP2 | |
| JP2021534124A5 (cg-RX-API-DMAC7.html) | ||
| JP7611278B2 (ja) | 金属酵素阻害剤化合物 | |
| JP6534675B2 (ja) | mIDH1阻害剤としてのベンズイミダゾール−2−アミン | |
| DK2526090T3 (en) | New antimalarials | |
| JP2008508214A (ja) | 女性の性障害の治療用ピペラジン誘導体 | |
| JP2014526500A5 (cg-RX-API-DMAC7.html) | ||
| WO2020247747A1 (en) | Bicyclic derivatives for treating endoparasites | |
| JP2005523922A5 (cg-RX-API-DMAC7.html) | ||
| JP2011504903A5 (cg-RX-API-DMAC7.html) | ||
| CA2710182A1 (en) | Pyrimidyl indoline compound | |
| JP2005517006A5 (cg-RX-API-DMAC7.html) | ||
| CA2628844A1 (en) | Pyrazole derivatives and their medical use | |
| CA2991360A1 (en) | 2-aryl- and 2-arylalkyl-benzimidazoles as midh1 inhibitors | |
| JP2015524843A5 (cg-RX-API-DMAC7.html) | ||
| JP2023512823A5 (cg-RX-API-DMAC7.html) | ||
| JP2022542140A5 (cg-RX-API-DMAC7.html) | ||
| JP2021529174A5 (cg-RX-API-DMAC7.html) | ||
| RU2403253C2 (ru) | Пуриновые производные для применения в качестве агонистов аденозинового рецептора а-2а | |
| US20240279207A1 (en) | Substituted acyl sulfonamides for treating cancer | |
| JP2004525183A5 (cg-RX-API-DMAC7.html) | ||
| RU2011108485A (ru) | Новые (поли)аминоалкиламиноалкиламидные, алкилмочевинные или алкилсульфонамидные производные эпиподофиллотоксина, способ их получения и их применение в терапии в качестве противораковых средств | |
| JP6184866B2 (ja) | 新規抗がん剤 | |
| ES2715394T3 (es) | Nuevo antifúngico derivado de oxodihidropiridinacarbohidrazida | |
| JP2026505827A (ja) | 治療剤として使用することができる新規化合物 |